Records containing: Pancreatic Ductal Adenocarcinoma (PDAC)

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2024-09-04
A Phase II, Randomized, Double-blind, Multi-center, Placebo-Controlled Study of the Efficacy and Safety of CEND-1 in Combination With Chemotherapy as First-Line Therapy in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Ductal Adenocarcinoma
CLINICAL_TRIALS study record update · 2024-01-16
PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer
CLINICAL_TRIALS study record update · 2023-11-30
Microbiota and Metabolites Alterations in Pancreatic Head and Body/Tail Cancer Patients
CLINICAL_TRIALS study record update · 2023-11-09
RPSA as a Potential Prognostic Biomarker of PDAC
CLINICAL_TRIALS study record update · 2023-10-24
"Effect of Screening Using Imaging (CT/ EUS) on Early Detection of Pancreatic Ductal Adenocarcinoma (PDAC) in Patients With New Onset Diabetes (NOD)" - A Prospective Pilot Observational Study
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2019-12-30
A Phase 1/1b Multicenter, Open-label, Dose-escalation, and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of MEDI7247 in Patients With Advanced or Metastatic Disease in Selected Solid Tumors
CLINICAL_TRIALS study record update · 2019-03-19
Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study
CLINICAL_TRIALS study record update · 2018-04-10
Diagnostic Accuracy of Circulating Tumor Cells (CTCs) and Onco-exosome Quantification in the Diagnosis of Pancreatic Cancer - PANC-CTC